Access cutting-edge atrial fibrillation (af) treatment through this clinical trial at a research site in Dothan. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Dothan location
Preparing your pre-screening questions…
Access atrial fibrillation (af) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atrial fibrillation (af) treatment provided free
Check if you qualify for this atrial fibrillation (af) clinical trial in Dothan, AL
No-Cost Study Care
Local to Dothan
Convenient for AL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is researching experimental drugs called REGN7508 and REGN9933. The study is focused on participants who have atrial fibrillation, which means that the heart beats too fast and unevenly. REGN7508 and REGN9933 are designed to help stop blood clots forming in patients with atrial fibrillation. The aim of the study is to see how well REGN7508 and REGN9933 work in patients that get medicine for their atrial fibrillation. The bleeding effects of REGN7508 and REGN9933 will be compared to another medicine (apixaban), which is available on the market to treat and prevent formation of blood clots. The study is looking at several other research questions, including: * What side effects may happen from taking REGN7508 or REGN9933 * How well do the study drugs reduce the risk of having a stroke * How much of REGN7508 or REGN9933 is in the blood at different times * Whether the body makes antibodies against REGN7508 or REGN9933 (which could make the drugs less effective or could lead to side effects)
Sponsor: Regeneron Pharmaceuticals
Yes, this clinical trial (NCT07175428) has an active research site in Dothan, AL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for atrial fibrillation (af) treatment options in Dothan, AL, this clinical trial (NCT07175428) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Dothan research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atrial fibrillation (af) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all atrial fibrillation (af) clinical trials near you to find additional studies recruiting in your area.
See all atrial fibrillation clinical trials recruiting in Dothan — not just this study.
Browse Atrial Fibrillation Trials in Dothan →